Neuroprotection and Neuroregeneration for Retinal Diseases

This book provides the latest findings on neuroprotection and neuroregeneration as potential therapeutic strategies for various eye diseases, namely, glaucoma, age-related macular degeneration (AMD), retinal detachment, and retinitis pigmentosa. Glaucoma is one of the main causes of blindness throug...

Full description

Bibliographic Details
Other Authors: Nakazawa, Toru (Editor), Kitaoka, Yasushi (Editor), Harada, Takayuki (Editor)
Format: eBook
Language:English
Published: Tokyo Springer Japan 2014, 2014
Edition:1st ed. 2014
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 03618nmm a2200337 u 4500
001 EB000892167
003 EBX01000000000000000689287
005 00000000000000.0
007 cr|||||||||||||||||||||
008 140801 ||| eng
020 |a 9784431549659 
100 1 |a Nakazawa, Toru  |e [editor] 
245 0 0 |a Neuroprotection and Neuroregeneration for Retinal Diseases  |h Elektronische Ressource  |c edited by Toru Nakazawa, Yasushi Kitaoka, Takayuki Harada 
250 |a 1st ed. 2014 
260 |a Tokyo  |b Springer Japan  |c 2014, 2014 
300 |a X, 356 p. 85 illus., 61 illus. in color  |b online resource 
505 0 |a Part I Neuroprotection for Glaucoma -- 1. Molecular Architecture of Glutamate Signaling Pathway in Glaucomatous Optic Neuropathy -- 2. Calcium and Calpain Activation -- 3. Classical Signaling Pathways -- 4. Antioxidative Treatment for Neuroprotection in Glaucoma -- 5. ER stress -- 6. Nitric Oxide Contributes to Retinal Ganglion Cell Survival Through Protein S-Nitrosylation after Optic Nerve Injury -- 7. Neurotrophic factors -- 8. RIP Kinase-Mediated Programmed Necrosis -- 9. Axonal Degeneration -- 10. Axonal Transport -- 11. Interaction Between RGC Bodies and Glia -- 12. Aquaporin in optic neuropathies -- 13. Microglia -- Part II Neuroprotection for Age-Related Macular Degeneration (AMD), Retinal Pigmentary Degeneration -- 14. Neuroprotection for Photoreceptors -- 15. Retinal Photooxidative Stress and Its Modifiers -- 16. Roles of the Retinal Pigment Epithelium in Neuroprotection -- 17. Oxidative Stress in the RPE and Its Contribution to AMD Pathogenesis; Implication of Light Exposure -- 18. Interaction Between Photoreceptors and RPEs -- Part III Neuroprotection for Other Retinal Diseases -- 19. Neuroprotection for Retinal Detachment -- 20. Neuroinflammation -- 21. Optic Neuritis -- 22. Neuroprotection by Endothelial Progenitor Cells for Retinal Degeneration -- 23. Optic Nerve Regeneration 
653 |a Regenerative Medicine/Tissue Engineering 
653 |a Neurology  
653 |a Ophthalmology 
653 |a Ophthalmology 
653 |a Neurology 
653 |a Tissue engineering 
653 |a Regenerative medicine 
700 1 |a Kitaoka, Yasushi  |e [editor] 
700 1 |a Harada, Takayuki  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
856 4 0 |u https://doi.org/10.1007/978-4-431-54965-9?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 617.7 
520 |a This book provides the latest findings on neuroprotection and neuroregeneration as potential therapeutic strategies for various eye diseases, namely, glaucoma, age-related macular degeneration (AMD), retinal detachment, and retinitis pigmentosa. Glaucoma is one of the main causes of blindness throughout the world, and other diseases such as AMD and retinitis pigmentosa also lead to loss of vision. All these conditions are characterized by degeneration of specific retinal cell types, making it essential to establish treatments to protect retinal neurons and the optic nerve. With that aim in mind, this book explains the mechanisms underlying aforementioned diseases and their experimental models. The novel strategy proposals for the treatment of retinal diseases based on the concept of neuroprotection are also discussed in the main body of the text, while the section on regenerative research discusses optic nerve regeneration, endothelial progenitor cells, and iPS cells. This book is recommended as a professional reference work for all doctors and trainees in the field of ophthalmology who are interested in neuroprotective and neuroregenerative treatments